nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicotine—SLC22A5—Dactinomycin—skin cancer	0.0773	0.116	CbGbCtD
Nicotine—CYP1A2—Imiquimod—skin cancer	0.0616	0.0923	CbGbCtD
Nicotine—CYP1A1—Dacarbazine—skin cancer	0.0579	0.0867	CbGbCtD
Nicotine—CYP2C8—Vismodegib—skin cancer	0.0552	0.0826	CbGbCtD
Nicotine—CYP2C19—Vismodegib—skin cancer	0.0463	0.0693	CbGbCtD
Nicotine—CYP2E1—Dacarbazine—skin cancer	0.0447	0.067	CbGbCtD
Nicotine—CYP2A6—Fluorouracil—skin cancer	0.0397	0.0595	CbGbCtD
Nicotine—CYP2C9—Vismodegib—skin cancer	0.0385	0.0576	CbGbCtD
Nicotine—CYP2A13—nose—skin cancer	0.0339	0.279	CbGeAlD
Nicotine—CYP1A2—Vemurafenib—skin cancer	0.0338	0.0506	CbGbCtD
Nicotine—CYP3A4—Imiquimod—skin cancer	0.0323	0.0483	CbGbCtD
Nicotine—CYP3A4—Temozolomide—skin cancer	0.0323	0.0483	CbGbCtD
Nicotine—CYP2D6—Vemurafenib—skin cancer	0.0278	0.0417	CbGbCtD
Nicotine—CYP1A2—Dacarbazine—skin cancer	0.0259	0.0387	CbGbCtD
Nicotine—CYP3A4—Vismodegib—skin cancer	0.0224	0.0335	CbGbCtD
Nicotine—CYP2C8—Fluorouracil—skin cancer	0.0196	0.0293	CbGbCtD
Nicotine—CYP3A4—Vemurafenib—skin cancer	0.0177	0.0265	CbGbCtD
Nicotine—CYP1A2—Fluorouracil—skin cancer	0.0152	0.0227	CbGbCtD
Nicotine—CYP2C9—Fluorouracil—skin cancer	0.0137	0.0205	CbGbCtD
Nicotine—CHRNA10—ear—skin cancer	0.00803	0.0661	CbGeAlD
Nicotine—CYP3A4—Docetaxel—skin cancer	0.00607	0.00909	CbGbCtD
Nicotine—CHAT—nerve—skin cancer	0.00525	0.0432	CbGeAlD
Nicotine—CHRNA3—skin epidermis—skin cancer	0.00413	0.034	CbGeAlD
Nicotine—CHRNA9—mammalian vulva—skin cancer	0.00379	0.0312	CbGeAlD
Nicotine—CHRNA7—skin epidermis—skin cancer	0.0027	0.0222	CbGeAlD
Nicotine—CHRNA6—skin of body—skin cancer	0.0023	0.0189	CbGeAlD
Nicotine—CHRNA4—nerve—skin cancer	0.00227	0.0187	CbGeAlD
Nicotine—CHRNB2—nipple—skin cancer	0.00206	0.017	CbGeAlD
Nicotine—CHRNA5—head—skin cancer	0.00198	0.0163	CbGeAlD
Nicotine—CHRNB3—head—skin cancer	0.0018	0.0148	CbGeAlD
Nicotine—MAOB—nerve—skin cancer	0.0017	0.014	CbGeAlD
Nicotine—CHAT—lymphoid tissue—skin cancer	0.00155	0.0127	CbGeAlD
Nicotine—CHRNA6—head—skin cancer	0.0015	0.0123	CbGeAlD
Nicotine—CHAT—female reproductive system—skin cancer	0.00149	0.0123	CbGeAlD
Nicotine—CHRNA10—lymphoid tissue—skin cancer	0.00149	0.0122	CbGeAlD
Nicotine—MAOA—nerve—skin cancer	0.00145	0.0119	CbGeAlD
Nicotine—CYP1A1—skin epidermis—skin cancer	0.0014	0.0115	CbGeAlD
Nicotine—CHRNA5—lymph node—skin cancer	0.00139	0.0114	CbGeAlD
Nicotine—CHRNB4—head—skin cancer	0.00136	0.0112	CbGeAlD
Nicotine—CHRNA7—neck—skin cancer	0.00129	0.0106	CbGeAlD
Nicotine—CHRNA3—skin of body—skin cancer	0.00128	0.0105	CbGeAlD
Nicotine—CHAT—head—skin cancer	0.00125	0.0103	CbGeAlD
Nicotine—CHRNB2—mammalian vulva—skin cancer	0.0012	0.00991	CbGeAlD
Nicotine—CHRNA10—head—skin cancer	0.0012	0.00987	CbGeAlD
Nicotine—SLC22A4—neck—skin cancer	0.00113	0.00931	CbGeAlD
Nicotine—SLC22A3—nipple—skin cancer	0.00104	0.00857	CbGeAlD
Nicotine—CHRNA3—lymphoid tissue—skin cancer	0.00104	0.00853	CbGeAlD
Nicotine—MAOB—nipple—skin cancer	0.000963	0.00793	CbGeAlD
Nicotine—CHRNB2—head—skin cancer	0.000862	0.00709	CbGeAlD
Nicotine—CHRNA10—lymph node—skin cancer	0.00084	0.00691	CbGeAlD
Nicotine—CHRNA7—skin of body—skin cancer	0.000837	0.00688	CbGeAlD
Nicotine—CHRNA3—head—skin cancer	0.000836	0.00688	CbGeAlD
Nicotine—MAOA—nipple—skin cancer	0.000822	0.00676	CbGeAlD
Nicotine—MAOA—neck—skin cancer	0.000813	0.00669	CbGeAlD
Nicotine—CHRFAM7A—female reproductive system—skin cancer	0.000809	0.00666	CbGeAlD
Nicotine—CHRNA2—head—skin cancer	0.000777	0.00639	CbGeAlD
Nicotine—SLC22A5—nipple—skin cancer	0.000757	0.00623	CbGeAlD
Nicotine—SLC22A3—connective tissue—skin cancer	0.000738	0.00608	CbGeAlD
Nicotine—CYP19A1—connective tissue—skin cancer	0.000726	0.00597	CbGeAlD
Nicotine—CYP1A2—nipple—skin cancer	0.000686	0.00564	CbGeAlD
Nicotine—MAOB—connective tissue—skin cancer	0.000683	0.00562	CbGeAlD
Nicotine—CYP1A1—nipple—skin cancer	0.000676	0.00557	CbGeAlD
Nicotine—CHRFAM7A—head—skin cancer	0.000676	0.00556	CbGeAlD
Nicotine—CHRNA7—female reproductive system—skin cancer	0.000653	0.00538	CbGeAlD
Nicotine—SLC22A3—mammalian vulva—skin cancer	0.000608	0.005	CbGeAlD
Nicotine—CHRNB2—lymph node—skin cancer	0.000603	0.00496	CbGeAlD
Nicotine—CHRNA3—lymph node—skin cancer	0.000585	0.00482	CbGeAlD
Nicotine—MAOA—connective tissue—skin cancer	0.000583	0.0048	CbGeAlD
Nicotine—SLC22A4—female reproductive system—skin cancer	0.000572	0.00471	CbGeAlD
Nicotine—MAOB—mammalian vulva—skin cancer	0.000563	0.00463	CbGeAlD
Nicotine—CHRNA7—head—skin cancer	0.000546	0.00449	CbGeAlD
Nicotine—CHRNA4—head—skin cancer	0.000538	0.00443	CbGeAlD
Nicotine—SLC22A3—female reproductive system—skin cancer	0.000521	0.00428	CbGeAlD
Nicotine—MAOB—Dopamine metabolism—TYR—skin cancer	0.000512	0.21	CbGpPWpGaD
Nicotine—CYP19A1—female reproductive system—skin cancer	0.000512	0.00421	CbGeAlD
Nicotine—SLC22A5—skin of body—skin cancer	0.000485	0.00399	CbGeAlD
Nicotine—MAOB—female reproductive system—skin cancer	0.000482	0.00396	CbGeAlD
Nicotine—MAOA—mammalian vulva—skin cancer	0.00048	0.00395	CbGeAlD
Nicotine—CYP1A1—epithelium—skin cancer	0.000455	0.00375	CbGeAlD
Nicotine—SLC22A1—head—skin cancer	0.000455	0.00375	CbGeAlD
Nicotine—Hyperhidrosis—Imiquimod—skin cancer	0.000444	0.00213	CcSEcCtD
Nicotine—Weight increased—Temozolomide—skin cancer	0.00044	0.00211	CcSEcCtD
Nicotine—SLC22A3—head—skin cancer	0.000435	0.00358	CbGeAlD
Nicotine—CYP1A1—skin of body—skin cancer	0.000433	0.00356	CbGeAlD
Nicotine—CYP19A1—head—skin cancer	0.000428	0.00352	CbGeAlD
Nicotine—Flushing—Bleomycin—skin cancer	0.000426	0.00205	CcSEcCtD
Nicotine—Body temperature increased—Vemurafenib—skin cancer	0.000425	0.00204	CcSEcCtD
Nicotine—Pharyngitis—Dactinomycin—skin cancer	0.000425	0.00204	CcSEcCtD
Nicotine—CYP2B6—skin of body—skin cancer	0.000421	0.00346	CbGeAlD
Nicotine—Stomatitis—Temozolomide—skin cancer	0.00042	0.00202	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000418	0.00201	CcSEcCtD
Nicotine—Insomnia—Imiquimod—skin cancer	0.000415	0.00199	CcSEcCtD
Nicotine—Paraesthesia—Imiquimod—skin cancer	0.000412	0.00198	CcSEcCtD
Nicotine—MAOA—female reproductive system—skin cancer	0.000411	0.00338	CbGeAlD
Nicotine—Dyspnoea—Imiquimod—skin cancer	0.000409	0.00196	CcSEcCtD
Nicotine—Somnolence—Imiquimod—skin cancer	0.000408	0.00196	CcSEcCtD
Nicotine—Sinusitis—Temozolomide—skin cancer	0.000404	0.00194	CcSEcCtD
Nicotine—Dyspepsia—Imiquimod—skin cancer	0.000404	0.00194	CcSEcCtD
Nicotine—MAOB—head—skin cancer	0.000402	0.00331	CbGeAlD
Nicotine—Erythema—Bleomycin—skin cancer	0.000399	0.00192	CcSEcCtD
Nicotine—Hot flush—Docetaxel—skin cancer	0.000398	0.00191	CcSEcCtD
Nicotine—Flushing—Dactinomycin—skin cancer	0.000397	0.00191	CcSEcCtD
Nicotine—Hypersensitivity—Vemurafenib—skin cancer	0.000396	0.0019	CcSEcCtD
Nicotine—Gastrointestinal disorder—Imiquimod—skin cancer	0.000396	0.0019	CcSEcCtD
Nicotine—Fatigue—Imiquimod—skin cancer	0.000396	0.0019	CcSEcCtD
Nicotine—CYP1A1—mammalian vulva—skin cancer	0.000395	0.00325	CbGeAlD
Nicotine—Menopausal symptoms—Docetaxel—skin cancer	0.000394	0.00189	CcSEcCtD
Nicotine—Atrial fibrillation—Docetaxel—skin cancer	0.000393	0.00189	CcSEcCtD
Nicotine—Pain—Imiquimod—skin cancer	0.000392	0.00188	CcSEcCtD
Nicotine—Dermatitis bullous—Docetaxel—skin cancer	0.000389	0.00187	CcSEcCtD
Nicotine—Stomatitis—Fluorouracil—skin cancer	0.000387	0.00186	CcSEcCtD
Nicotine—Asthenia—Vemurafenib—skin cancer	0.000386	0.00185	CcSEcCtD
Nicotine—Hypoaesthesia—Temozolomide—skin cancer	0.000385	0.00185	CcSEcCtD
Nicotine—Pharyngitis—Temozolomide—skin cancer	0.000384	0.00184	CcSEcCtD
Nicotine—Oedema peripheral—Temozolomide—skin cancer	0.000381	0.00183	CcSEcCtD
Nicotine—Cardiac failure—Docetaxel—skin cancer	0.000381	0.00183	CcSEcCtD
Nicotine—Pruritus—Vemurafenib—skin cancer	0.000381	0.00183	CcSEcCtD
Nicotine—SLC22A5—female reproductive system—skin cancer	0.000379	0.00312	CbGeAlD
Nicotine—Feeling abnormal—Imiquimod—skin cancer	0.000378	0.00182	CcSEcCtD
Nicotine—Gastrointestinal pain—Imiquimod—skin cancer	0.000375	0.0018	CcSEcCtD
Nicotine—Epistaxis—Fluorouracil—skin cancer	0.000375	0.0018	CcSEcCtD
Nicotine—Visual impairment—Temozolomide—skin cancer	0.000373	0.00179	CcSEcCtD
Nicotine—Sinusitis—Fluorouracil—skin cancer	0.000373	0.00179	CcSEcCtD
Nicotine—Erythema—Dactinomycin—skin cancer	0.000373	0.00179	CcSEcCtD
Nicotine—Ill-defined disorder—Bleomycin—skin cancer	0.000371	0.00178	CcSEcCtD
Nicotine—Diarrhoea—Vemurafenib—skin cancer	0.000368	0.00177	CcSEcCtD
Nicotine—CYP2C8—female reproductive system—skin cancer	0.000366	0.00302	CbGeAlD
Nicotine—Migraine—Docetaxel—skin cancer	0.000366	0.00176	CcSEcCtD
Nicotine—Urticaria—Imiquimod—skin cancer	0.000365	0.00175	CcSEcCtD
Nicotine—Abdominal pain—Imiquimod—skin cancer	0.000363	0.00174	CcSEcCtD
Nicotine—Body temperature increased—Imiquimod—skin cancer	0.000363	0.00174	CcSEcCtD
Nicotine—Malaise—Bleomycin—skin cancer	0.00036	0.00173	CcSEcCtD
Nicotine—Cardiac disorder—Temozolomide—skin cancer	0.000359	0.00173	CcSEcCtD
Nicotine—Flushing—Temozolomide—skin cancer	0.000359	0.00173	CcSEcCtD
Nicotine—Rhinitis—Fluorouracil—skin cancer	0.000358	0.00172	CcSEcCtD
Nicotine—Dizziness—Vemurafenib—skin cancer	0.000356	0.00171	CcSEcCtD
Nicotine—Hypoaesthesia—Fluorouracil—skin cancer	0.000355	0.0017	CcSEcCtD
Nicotine—Pharyngitis—Fluorouracil—skin cancer	0.000354	0.0017	CcSEcCtD
Nicotine—Immune system disorder—Temozolomide—skin cancer	0.00035	0.00168	CcSEcCtD
Nicotine—Mediastinal disorder—Temozolomide—skin cancer	0.000349	0.00168	CcSEcCtD
Nicotine—Cough—Bleomycin—skin cancer	0.000349	0.00167	CcSEcCtD
Nicotine—Ill-defined disorder—Dactinomycin—skin cancer	0.000346	0.00166	CcSEcCtD
Nicotine—MAOA—head—skin cancer	0.000343	0.00283	CbGeAlD
Nicotine—Vomiting—Vemurafenib—skin cancer	0.000342	0.00164	CcSEcCtD
Nicotine—CYP2B6—lymphoid tissue—skin cancer	0.000341	0.0028	CbGeAlD
Nicotine—Chest pain—Bleomycin—skin cancer	0.00034	0.00163	CcSEcCtD
Nicotine—Myalgia—Bleomycin—skin cancer	0.00034	0.00163	CcSEcCtD
Nicotine—Abdominal pain upper—Docetaxel—skin cancer	0.00034	0.00163	CcSEcCtD
Nicotine—Rash—Vemurafenib—skin cancer	0.000339	0.00163	CcSEcCtD
Nicotine—Mental disorder—Temozolomide—skin cancer	0.000339	0.00163	CcSEcCtD
Nicotine—Dermatitis—Vemurafenib—skin cancer	0.000339	0.00163	CcSEcCtD
Nicotine—CYP1A1—female reproductive system—skin cancer	0.000338	0.00278	CbGeAlD
Nicotine—Hypersensitivity—Imiquimod—skin cancer	0.000338	0.00162	CcSEcCtD
Nicotine—Headache—Vemurafenib—skin cancer	0.000337	0.00162	CcSEcCtD
Nicotine—Erythema—Temozolomide—skin cancer	0.000337	0.00162	CcSEcCtD
Nicotine—Discomfort—Bleomycin—skin cancer	0.000336	0.00161	CcSEcCtD
Nicotine—Malaise—Dactinomycin—skin cancer	0.000336	0.00161	CcSEcCtD
Nicotine—SLC22A4—lymph node—skin cancer	0.000335	0.00275	CbGeAlD
Nicotine—Nasopharyngitis—Docetaxel—skin cancer	0.000333	0.0016	CcSEcCtD
Nicotine—Dysgeusia—Temozolomide—skin cancer	0.00033	0.00158	CcSEcCtD
Nicotine—Asthenia—Imiquimod—skin cancer	0.000329	0.00158	CcSEcCtD
Nicotine—CYP2B6—female reproductive system—skin cancer	0.000329	0.00271	CbGeAlD
Nicotine—Confusional state—Bleomycin—skin cancer	0.000329	0.00158	CcSEcCtD
Nicotine—Anaphylactic shock—Bleomycin—skin cancer	0.000326	0.00157	CcSEcCtD
Nicotine—Oedema—Bleomycin—skin cancer	0.000326	0.00157	CcSEcCtD
Nicotine—Back pain—Temozolomide—skin cancer	0.000326	0.00157	CcSEcCtD
Nicotine—CYP2C9—female reproductive system—skin cancer	0.000326	0.00268	CbGeAlD
Nicotine—Pruritus—Imiquimod—skin cancer	0.000325	0.00156	CcSEcCtD
Nicotine—Dysphagia—Docetaxel—skin cancer	0.000322	0.00154	CcSEcCtD
Nicotine—MAOA—Dopamine metabolism—TYR—skin cancer	0.000322	0.132	CbGpPWpGaD
Nicotine—CYP2E1—lymphoid tissue—skin cancer	0.00032	0.00263	CbGeAlD
Nicotine—Nausea—Vemurafenib—skin cancer	0.00032	0.00153	CcSEcCtD
Nicotine—Arrhythmia—Fluorouracil—skin cancer	0.000319	0.00153	CcSEcCtD
Nicotine—Myalgia—Dactinomycin—skin cancer	0.000317	0.00152	CcSEcCtD
Nicotine—Bronchospasm—Docetaxel—skin cancer	0.000316	0.00152	CcSEcCtD
Nicotine—Tremor—Temozolomide—skin cancer	0.000316	0.00152	CcSEcCtD
Nicotine—Diarrhoea—Imiquimod—skin cancer	0.000314	0.00151	CcSEcCtD
Nicotine—Discomfort—Dactinomycin—skin cancer	0.000313	0.0015	CcSEcCtD
Nicotine—Ill-defined disorder—Temozolomide—skin cancer	0.000313	0.0015	CcSEcCtD
Nicotine—Erythema—Fluorouracil—skin cancer	0.00031	0.00149	CcSEcCtD
Nicotine—Agitation—Temozolomide—skin cancer	0.00031	0.00149	CcSEcCtD
Nicotine—CYP2E1—female reproductive system—skin cancer	0.000309	0.00254	CbGeAlD
Nicotine—Angioedema—Temozolomide—skin cancer	0.000308	0.00148	CcSEcCtD
Nicotine—Hypotension—Bleomycin—skin cancer	0.000305	0.00146	CcSEcCtD
Nicotine—SLC22A3—lymph node—skin cancer	0.000305	0.00251	CbGeAlD
Nicotine—Oedema—Dactinomycin—skin cancer	0.000304	0.00146	CcSEcCtD
Nicotine—Malaise—Temozolomide—skin cancer	0.000304	0.00146	CcSEcCtD
Nicotine—Dizziness—Imiquimod—skin cancer	0.000303	0.00146	CcSEcCtD
Nicotine—Vertigo—Temozolomide—skin cancer	0.000303	0.00145	CcSEcCtD
Nicotine—CYP19A1—lymph node—skin cancer	0.000299	0.00246	CbGeAlD
Nicotine—Palpitations—Temozolomide—skin cancer	0.000298	0.00143	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000297	0.00143	CcSEcCtD
Nicotine—Cough—Temozolomide—skin cancer	0.000294	0.00141	CcSEcCtD
Nicotine—Paraesthesia—Bleomycin—skin cancer	0.000293	0.00141	CcSEcCtD
Nicotine—Weight increased—Docetaxel—skin cancer	0.000293	0.00141	CcSEcCtD
Nicotine—Convulsion—Temozolomide—skin cancer	0.000292	0.0014	CcSEcCtD
Nicotine—Vomiting—Imiquimod—skin cancer	0.000292	0.0014	CcSEcCtD
Nicotine—Hypertension—Temozolomide—skin cancer	0.000291	0.0014	CcSEcCtD
Nicotine—Dyspnoea—Bleomycin—skin cancer	0.000291	0.0014	CcSEcCtD
Nicotine—Rash—Imiquimod—skin cancer	0.000289	0.00139	CcSEcCtD
Nicotine—Dermatitis—Imiquimod—skin cancer	0.000289	0.00139	CcSEcCtD
Nicotine—Headache—Imiquimod—skin cancer	0.000287	0.00138	CcSEcCtD
Nicotine—Arthralgia—Temozolomide—skin cancer	0.000287	0.00138	CcSEcCtD
Nicotine—Myalgia—Temozolomide—skin cancer	0.000287	0.00138	CcSEcCtD
Nicotine—Anxiety—Temozolomide—skin cancer	0.000286	0.00137	CcSEcCtD
Nicotine—Discomfort—Temozolomide—skin cancer	0.000283	0.00136	CcSEcCtD
Nicotine—CYP1A1—head—skin cancer	0.000283	0.00233	CbGeAlD
Nicotine—MAOB—lymph node—skin cancer	0.000282	0.00232	CbGeAlD
Nicotine—Dry mouth—Temozolomide—skin cancer	0.000281	0.00135	CcSEcCtD
Nicotine—Stomatitis—Docetaxel—skin cancer	0.000279	0.00134	CcSEcCtD
Nicotine—Pain—Bleomycin—skin cancer	0.000279	0.00134	CcSEcCtD
Nicotine—Confusional state—Temozolomide—skin cancer	0.000277	0.00133	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000277	0.00133	CcSEcCtD
Nicotine—Oedema—Temozolomide—skin cancer	0.000275	0.00132	CcSEcCtD
Nicotine—Anaphylactic shock—Temozolomide—skin cancer	0.000275	0.00132	CcSEcCtD
Nicotine—CYP2B6—head—skin cancer	0.000275	0.00226	CbGeAlD
Nicotine—Nausea—Imiquimod—skin cancer	0.000273	0.00131	CcSEcCtD
Nicotine—Epistaxis—Docetaxel—skin cancer	0.00027	0.0013	CcSEcCtD
Nicotine—Nervous system disorder—Temozolomide—skin cancer	0.00027	0.0013	CcSEcCtD
Nicotine—Convulsion—Fluorouracil—skin cancer	0.000269	0.00129	CcSEcCtD
Nicotine—Feeling abnormal—Bleomycin—skin cancer	0.000269	0.00129	CcSEcCtD
Nicotine—Hyperhidrosis—Temozolomide—skin cancer	0.000266	0.00128	CcSEcCtD
Nicotine—Chest pain—Fluorouracil—skin cancer	0.000264	0.00127	CcSEcCtD
Nicotine—Myalgia—Fluorouracil—skin cancer	0.000264	0.00127	CcSEcCtD
Nicotine—Fatigue—Dactinomycin—skin cancer	0.000262	0.00126	CcSEcCtD
Nicotine—Discomfort—Fluorouracil—skin cancer	0.000261	0.00125	CcSEcCtD
Nicotine—Pain—Dactinomycin—skin cancer	0.00026	0.00125	CcSEcCtD
Nicotine—Urticaria—Bleomycin—skin cancer	0.000259	0.00124	CcSEcCtD
Nicotine—Rhinitis—Docetaxel—skin cancer	0.000258	0.00124	CcSEcCtD
Nicotine—CYP2E1—head—skin cancer	0.000258	0.00212	CbGeAlD
Nicotine—Body temperature increased—Bleomycin—skin cancer	0.000258	0.00124	CcSEcCtD
Nicotine—Hypoaesthesia—Docetaxel—skin cancer	0.000256	0.00123	CcSEcCtD
Nicotine—Confusional state—Fluorouracil—skin cancer	0.000255	0.00123	CcSEcCtD
Nicotine—Pharyngitis—Docetaxel—skin cancer	0.000255	0.00123	CcSEcCtD
Nicotine—Oedema peripheral—Docetaxel—skin cancer	0.000254	0.00122	CcSEcCtD
Nicotine—Anaphylactic shock—Fluorouracil—skin cancer	0.000253	0.00122	CcSEcCtD
Nicotine—Oedema—Fluorouracil—skin cancer	0.000253	0.00122	CcSEcCtD
Nicotine—Feeling abnormal—Dactinomycin—skin cancer	0.000251	0.0012	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000251	0.0012	CcSEcCtD
Nicotine—Insomnia—Temozolomide—skin cancer	0.000249	0.00119	CcSEcCtD
Nicotine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000249	0.00119	CcSEcCtD
Nicotine—Nervous system disorder—Fluorouracil—skin cancer	0.000248	0.00119	CcSEcCtD
Nicotine—CYP3A4—female reproductive system—skin cancer	0.000248	0.00204	CbGeAlD
Nicotine—Visual impairment—Docetaxel—skin cancer	0.000248	0.00119	CcSEcCtD
Nicotine—Tachycardia—Fluorouracil—skin cancer	0.000247	0.00119	CcSEcCtD
Nicotine—Paraesthesia—Temozolomide—skin cancer	0.000247	0.00119	CcSEcCtD
Nicotine—Dyspnoea—Temozolomide—skin cancer	0.000245	0.00118	CcSEcCtD
Nicotine—Somnolence—Temozolomide—skin cancer	0.000244	0.00117	CcSEcCtD
Nicotine—CYP2D6—female reproductive system—skin cancer	0.000244	0.00201	CbGeAlD
Nicotine—Dyspepsia—Temozolomide—skin cancer	0.000242	0.00116	CcSEcCtD
Nicotine—MAOA—lymph node—skin cancer	0.00024	0.00198	CbGeAlD
Nicotine—Abdominal pain—Dactinomycin—skin cancer	0.00024	0.00115	CcSEcCtD
Nicotine—Body temperature increased—Dactinomycin—skin cancer	0.00024	0.00115	CcSEcCtD
Nicotine—Hypersensitivity—Bleomycin—skin cancer	0.00024	0.00115	CcSEcCtD
Nicotine—Cardiac disorder—Docetaxel—skin cancer	0.000239	0.00115	CcSEcCtD
Nicotine—Flushing—Docetaxel—skin cancer	0.000239	0.00115	CcSEcCtD
Nicotine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000237	0.00114	CcSEcCtD
Nicotine—Fatigue—Temozolomide—skin cancer	0.000237	0.00114	CcSEcCtD
Nicotine—Hypotension—Fluorouracil—skin cancer	0.000237	0.00114	CcSEcCtD
Nicotine—Pain—Temozolomide—skin cancer	0.000235	0.00113	CcSEcCtD
Nicotine—Constipation—Temozolomide—skin cancer	0.000235	0.00113	CcSEcCtD
Nicotine—Asthenia—Bleomycin—skin cancer	0.000234	0.00112	CcSEcCtD
Nicotine—Immune system disorder—Docetaxel—skin cancer	0.000232	0.00112	CcSEcCtD
Nicotine—Mediastinal disorder—Docetaxel—skin cancer	0.000232	0.00111	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000231	0.00111	CcSEcCtD
Nicotine—Pruritus—Bleomycin—skin cancer	0.000231	0.00111	CcSEcCtD
Nicotine—Arrhythmia—Docetaxel—skin cancer	0.00023	0.0011	CcSEcCtD
Nicotine—Insomnia—Fluorouracil—skin cancer	0.000229	0.0011	CcSEcCtD
Nicotine—Paraesthesia—Fluorouracil—skin cancer	0.000228	0.00109	CcSEcCtD
Nicotine—Feeling abnormal—Temozolomide—skin cancer	0.000227	0.00109	CcSEcCtD
Nicotine—Dyspnoea—Fluorouracil—skin cancer	0.000226	0.00108	CcSEcCtD
Nicotine—Mental disorder—Docetaxel—skin cancer	0.000226	0.00108	CcSEcCtD
Nicotine—Somnolence—Fluorouracil—skin cancer	0.000225	0.00108	CcSEcCtD
Nicotine—Gastrointestinal pain—Temozolomide—skin cancer	0.000225	0.00108	CcSEcCtD
Nicotine—Erythema—Docetaxel—skin cancer	0.000224	0.00108	CcSEcCtD
Nicotine—Hypersensitivity—Dactinomycin—skin cancer	0.000224	0.00108	CcSEcCtD
Nicotine—Dyspepsia—Fluorouracil—skin cancer	0.000223	0.00107	CcSEcCtD
Nicotine—SLC22A5—lymph node—skin cancer	0.000221	0.00182	CbGeAlD
Nicotine—Dysgeusia—Docetaxel—skin cancer	0.000219	0.00105	CcSEcCtD
Nicotine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000219	0.00105	CcSEcCtD
Nicotine—Urticaria—Temozolomide—skin cancer	0.000218	0.00105	CcSEcCtD
Nicotine—Asthenia—Dactinomycin—skin cancer	0.000218	0.00105	CcSEcCtD
Nicotine—Abdominal pain—Temozolomide—skin cancer	0.000217	0.00104	CcSEcCtD
Nicotine—Body temperature increased—Temozolomide—skin cancer	0.000217	0.00104	CcSEcCtD
Nicotine—Back pain—Docetaxel—skin cancer	0.000217	0.00104	CcSEcCtD
Nicotine—Pain—Fluorouracil—skin cancer	0.000217	0.00104	CcSEcCtD
Nicotine—Muscle spasms—Docetaxel—skin cancer	0.000215	0.00103	CcSEcCtD
Nicotine—Feeling abnormal—Fluorouracil—skin cancer	0.000209	0.001	CcSEcCtD
Nicotine—Diarrhoea—Dactinomycin—skin cancer	0.000208	0.000999	CcSEcCtD
Nicotine—Vomiting—Bleomycin—skin cancer	0.000207	0.000995	CcSEcCtD
Nicotine—Rash—Bleomycin—skin cancer	0.000206	0.000987	CcSEcCtD
Nicotine—Dermatitis—Bleomycin—skin cancer	0.000205	0.000986	CcSEcCtD
Nicotine—CYP2D6—head—skin cancer	0.000204	0.00168	CbGeAlD
Nicotine—Hypersensitivity—Temozolomide—skin cancer	0.000203	0.000973	CcSEcCtD
Nicotine—Urticaria—Fluorouracil—skin cancer	0.000201	0.000967	CcSEcCtD
Nicotine—Syncope—Docetaxel—skin cancer	0.000201	0.000965	CcSEcCtD
Nicotine—Body temperature increased—Fluorouracil—skin cancer	0.0002	0.000962	CcSEcCtD
Nicotine—Palpitations—Docetaxel—skin cancer	0.000198	0.000951	CcSEcCtD
Nicotine—CYP1A1—lymph node—skin cancer	0.000198	0.00163	CbGeAlD
Nicotine—Asthenia—Temozolomide—skin cancer	0.000197	0.000947	CcSEcCtD
Nicotine—Loss of consciousness—Docetaxel—skin cancer	0.000197	0.000946	CcSEcCtD
Nicotine—Cough—Docetaxel—skin cancer	0.000196	0.000939	CcSEcCtD
Nicotine—Pruritus—Temozolomide—skin cancer	0.000195	0.000934	CcSEcCtD
Nicotine—Convulsion—Docetaxel—skin cancer	0.000194	0.000932	CcSEcCtD
Nicotine—Nausea—Bleomycin—skin cancer	0.000194	0.00093	CcSEcCtD
Nicotine—Hypertension—Docetaxel—skin cancer	0.000193	0.000929	CcSEcCtD
Nicotine—Vomiting—Dactinomycin—skin cancer	0.000193	0.000928	CcSEcCtD
Nicotine—Rash—Dactinomycin—skin cancer	0.000192	0.000921	CcSEcCtD
Nicotine—Arthralgia—Docetaxel—skin cancer	0.000191	0.000916	CcSEcCtD
Nicotine—Chest pain—Docetaxel—skin cancer	0.000191	0.000916	CcSEcCtD
Nicotine—Myalgia—Docetaxel—skin cancer	0.000191	0.000916	CcSEcCtD
Nicotine—Diarrhoea—Temozolomide—skin cancer	0.000188	0.000904	CcSEcCtD
Nicotine—Hypersensitivity—Fluorouracil—skin cancer	0.000187	0.000896	CcSEcCtD
Nicotine—Dry mouth—Docetaxel—skin cancer	0.000187	0.000896	CcSEcCtD
Nicotine—Confusional state—Docetaxel—skin cancer	0.000184	0.000886	CcSEcCtD
Nicotine—Oedema—Docetaxel—skin cancer	0.000183	0.000878	CcSEcCtD
Nicotine—Anaphylactic shock—Docetaxel—skin cancer	0.000183	0.000878	CcSEcCtD
Nicotine—Dizziness—Temozolomide—skin cancer	0.000182	0.000873	CcSEcCtD
Nicotine—Nausea—Dactinomycin—skin cancer	0.000181	0.000867	CcSEcCtD
Nicotine—Shock—Docetaxel—skin cancer	0.00018	0.000864	CcSEcCtD
Nicotine—Nervous system disorder—Docetaxel—skin cancer	0.000179	0.000861	CcSEcCtD
Nicotine—Pruritus—Fluorouracil—skin cancer	0.000179	0.000861	CcSEcCtD
Nicotine—Tachycardia—Docetaxel—skin cancer	0.000178	0.000857	CcSEcCtD
Nicotine—Vomiting—Temozolomide—skin cancer	0.000175	0.00084	CcSEcCtD
Nicotine—Rash—Temozolomide—skin cancer	0.000173	0.000833	CcSEcCtD
Nicotine—Diarrhoea—Fluorouracil—skin cancer	0.000173	0.000833	CcSEcCtD
Nicotine—Dermatitis—Temozolomide—skin cancer	0.000173	0.000832	CcSEcCtD
Nicotine—Headache—Temozolomide—skin cancer	0.000172	0.000827	CcSEcCtD
Nicotine—Hypotension—Docetaxel—skin cancer	0.000171	0.000821	CcSEcCtD
Nicotine—Dizziness—Fluorouracil—skin cancer	0.000168	0.000805	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000167	0.0008	CcSEcCtD
Nicotine—Insomnia—Docetaxel—skin cancer	0.000165	0.000794	CcSEcCtD
Nicotine—Paraesthesia—Docetaxel—skin cancer	0.000164	0.000789	CcSEcCtD
Nicotine—Nausea—Temozolomide—skin cancer	0.000163	0.000784	CcSEcCtD
Nicotine—Dyspnoea—Docetaxel—skin cancer	0.000163	0.000783	CcSEcCtD
Nicotine—Somnolence—Docetaxel—skin cancer	0.000163	0.000781	CcSEcCtD
Nicotine—Vomiting—Fluorouracil—skin cancer	0.000161	0.000774	CcSEcCtD
Nicotine—Dyspepsia—Docetaxel—skin cancer	0.000161	0.000773	CcSEcCtD
Nicotine—Rash—Fluorouracil—skin cancer	0.00016	0.000767	CcSEcCtD
Nicotine—Dermatitis—Fluorouracil—skin cancer	0.00016	0.000766	CcSEcCtD
Nicotine—Headache—Fluorouracil—skin cancer	0.000159	0.000762	CcSEcCtD
Nicotine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000158	0.000758	CcSEcCtD
Nicotine—Fatigue—Docetaxel—skin cancer	0.000158	0.000757	CcSEcCtD
Nicotine—Constipation—Docetaxel—skin cancer	0.000156	0.000751	CcSEcCtD
Nicotine—Pain—Docetaxel—skin cancer	0.000156	0.000751	CcSEcCtD
Nicotine—Feeling abnormal—Docetaxel—skin cancer	0.000151	0.000724	CcSEcCtD
Nicotine—Nausea—Fluorouracil—skin cancer	0.00015	0.000723	CcSEcCtD
Nicotine—Gastrointestinal pain—Docetaxel—skin cancer	0.00015	0.000718	CcSEcCtD
Nicotine—Abdominal pain—Docetaxel—skin cancer	0.000145	0.000694	CcSEcCtD
Nicotine—Body temperature increased—Docetaxel—skin cancer	0.000145	0.000694	CcSEcCtD
Nicotine—Hypersensitivity—Docetaxel—skin cancer	0.000135	0.000647	CcSEcCtD
Nicotine—Asthenia—Docetaxel—skin cancer	0.000131	0.00063	CcSEcCtD
Nicotine—Pruritus—Docetaxel—skin cancer	0.000129	0.000621	CcSEcCtD
Nicotine—Diarrhoea—Docetaxel—skin cancer	0.000125	0.000601	CcSEcCtD
Nicotine—Dizziness—Docetaxel—skin cancer	0.000121	0.000581	CcSEcCtD
Nicotine—Vomiting—Docetaxel—skin cancer	0.000116	0.000558	CcSEcCtD
Nicotine—Rash—Docetaxel—skin cancer	0.000115	0.000554	CcSEcCtD
Nicotine—Dermatitis—Docetaxel—skin cancer	0.000115	0.000553	CcSEcCtD
Nicotine—Headache—Docetaxel—skin cancer	0.000115	0.00055	CcSEcCtD
Nicotine—SLC22A3—Synaptic Vesicle Pathway—SYP—skin cancer	0.00011	0.0452	CbGpPWpGaD
Nicotine—Nausea—Docetaxel—skin cancer	0.000109	0.000522	CcSEcCtD
Nicotine—CYP2A6—Fluoropyrimidine Activity—XRCC3—skin cancer	5.79e-05	0.0238	CbGpPWpGaD
Nicotine—CHRNB2—Circadian rythm related genes—NKX2-1—skin cancer	4.92e-05	0.0202	CbGpPWpGaD
Nicotine—CYP19A1—Ovarian Infertility Genes—MLH1—skin cancer	4.33e-05	0.0178	CbGpPWpGaD
Nicotine—CHRNA9—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	2.96e-05	0.0122	CbGpPWpGaD
Nicotine—CHAT—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.88e-05	0.0118	CbGpPWpGaD
Nicotine—SLC22A4—SLC-mediated transmembrane transport—SLC12A2—skin cancer	2.68e-05	0.011	CbGpPWpGaD
Nicotine—CHRNB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	2.59e-05	0.0106	CbGpPWpGaD
Nicotine—CHRNA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	2.45e-05	0.0101	CbGpPWpGaD
Nicotine—CHRNA9—Transmission across Chemical Synapses—BRAF—skin cancer	2.23e-05	0.00914	CbGpPWpGaD
Nicotine—CYP19A1—Ovarian Infertility Genes—CDK4—skin cancer	2.2e-05	0.00903	CbGpPWpGaD
Nicotine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—skin cancer	2.18e-05	0.00895	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—XRCC3—skin cancer	2.15e-05	0.00884	CbGpPWpGaD
Nicotine—CYP2A6—Fluoropyrimidine Activity—ERCC2—skin cancer	2.04e-05	0.00836	CbGpPWpGaD
Nicotine—SLC22A3—SLC-mediated transmembrane transport—SLC12A2—skin cancer	2.02e-05	0.0083	CbGpPWpGaD
Nicotine—SLC22A5—SLC-mediated transmembrane transport—SLC12A2—skin cancer	2.01e-05	0.00827	CbGpPWpGaD
Nicotine—CHRNB3—Transmission across Chemical Synapses—BRAF—skin cancer	1.95e-05	0.00799	CbGpPWpGaD
Nicotine—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	1.86e-05	0.00763	CbGpPWpGaD
Nicotine—CHRNA5—Transmission across Chemical Synapses—BRAF—skin cancer	1.84e-05	0.00757	CbGpPWpGaD
Nicotine—CYP1A1—PPARA activates gene expression—PLIN2—skin cancer	1.82e-05	0.00747	CbGpPWpGaD
Nicotine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PLIN2—skin cancer	1.78e-05	0.00731	CbGpPWpGaD
Nicotine—CHRNA9—Neuronal System—BRAF—skin cancer	1.71e-05	0.007	CbGpPWpGaD
Nicotine—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	1.64e-05	0.00672	CbGpPWpGaD
Nicotine—CHAT—Transmission across Chemical Synapses—BRAF—skin cancer	1.57e-05	0.00644	CbGpPWpGaD
Nicotine—CHRNB3—Neuronal System—BRAF—skin cancer	1.49e-05	0.00612	CbGpPWpGaD
Nicotine—CHRNA5—Neuronal System—BRAF—skin cancer	1.41e-05	0.0058	CbGpPWpGaD
Nicotine—CHRNA6—Transmission across Chemical Synapses—BRAF—skin cancer	1.4e-05	0.00574	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—MSH2—skin cancer	1.39e-05	0.0057	CbGpPWpGaD
Nicotine—CHRNB2—Circadian rythm related genes—CDK4—skin cancer	1.39e-05	0.00569	CbGpPWpGaD
Nicotine—SLC22A4—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.36e-05	0.00559	CbGpPWpGaD
Nicotine—CHRNA9—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	1.36e-05	0.00559	CbGpPWpGaD
Nicotine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	1.29e-05	0.00529	CbGpPWpGaD
Nicotine—CHAT—Metabolism—PLIN2—skin cancer	1.28e-05	0.00526	CbGpPWpGaD
Nicotine—SLC22A2—SLC-mediated transmembrane transport—SLC12A2—skin cancer	1.27e-05	0.0052	CbGpPWpGaD
Nicotine—CHRNB2—Transmission across Chemical Synapses—BRAF—skin cancer	1.23e-05	0.00505	CbGpPWpGaD
Nicotine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	1.23e-05	0.00504	CbGpPWpGaD
Nicotine—CHAT—Neuronal System—BRAF—skin cancer	1.2e-05	0.00493	CbGpPWpGaD
Nicotine—CHRNB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	1.19e-05	0.00488	CbGpPWpGaD
Nicotine—SLC22A1—SLC-mediated transmembrane transport—SLC12A2—skin cancer	1.18e-05	0.00485	CbGpPWpGaD
Nicotine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	1.18e-05	0.00484	CbGpPWpGaD
Nicotine—CHRNA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	1.13e-05	0.00463	CbGpPWpGaD
Nicotine—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	1.12e-05	0.00459	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—PLIN2—skin cancer	1.09e-05	0.00447	CbGpPWpGaD
Nicotine—CHRNA6—Neuronal System—BRAF—skin cancer	1.07e-05	0.0044	CbGpPWpGaD
Nicotine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	1.05e-05	0.00432	CbGpPWpGaD
Nicotine—CHAT—Metabolism—CSPG4—skin cancer	1.03e-05	0.00424	CbGpPWpGaD
Nicotine—SLC22A3—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.03e-05	0.00422	CbGpPWpGaD
Nicotine—SLC22A5—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.02e-05	0.0042	CbGpPWpGaD
Nicotine—CHRNA9—Transmission across Chemical Synapses—HRAS—skin cancer	1.02e-05	0.0042	CbGpPWpGaD
Nicotine—CHRNB4—Transmission across Chemical Synapses—BRAF—skin cancer	9.69e-06	0.00398	CbGpPWpGaD
Nicotine—CHRNB2—Neuronal System—BRAF—skin cancer	9.43e-06	0.00387	CbGpPWpGaD
Nicotine—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	9.12e-06	0.00374	CbGpPWpGaD
Nicotine—CHRNB3—Transmission across Chemical Synapses—HRAS—skin cancer	8.94e-06	0.00367	CbGpPWpGaD
Nicotine—CHRNA3—Transmission across Chemical Synapses—BRAF—skin cancer	8.86e-06	0.00364	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—CSPG4—skin cancer	8.78e-06	0.0036	CbGpPWpGaD
Nicotine—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	8.55e-06	0.00351	CbGpPWpGaD
Nicotine—CHRNA5—Transmission across Chemical Synapses—HRAS—skin cancer	8.48e-06	0.00348	CbGpPWpGaD
Nicotine—CHAT—SIDS Susceptibility Pathways—IL6—skin cancer	8.42e-06	0.00346	CbGpPWpGaD
Nicotine—CHRNA7—Transmission across Chemical Synapses—BRAF—skin cancer	8.41e-06	0.00345	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	8.24e-06	0.00338	CbGpPWpGaD
Nicotine—CHRNA2—Transmission across Chemical Synapses—BRAF—skin cancer	7.9e-06	0.00325	CbGpPWpGaD
Nicotine—CHRNA9—Neuronal System—HRAS—skin cancer	7.84e-06	0.00322	CbGpPWpGaD
Nicotine—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	7.53e-06	0.00309	CbGpPWpGaD
Nicotine—CHRNB4—Neuronal System—BRAF—skin cancer	7.42e-06	0.00305	CbGpPWpGaD
Nicotine—CYP2A6—Fluoropyrimidine Activity—TP53—skin cancer	7.27e-06	0.00298	CbGpPWpGaD
Nicotine—CHAT—Transmission across Chemical Synapses—HRAS—skin cancer	7.21e-06	0.00296	CbGpPWpGaD
Nicotine—CHAT—Metabolism—ENO2—skin cancer	7.02e-06	0.00288	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	6.97e-06	0.00286	CbGpPWpGaD
Nicotine—CHRNA4—Transmission across Chemical Synapses—BRAF—skin cancer	6.85e-06	0.00281	CbGpPWpGaD
Nicotine—CHRNB3—Neuronal System—HRAS—skin cancer	6.85e-06	0.00281	CbGpPWpGaD
Nicotine—CHRNA3—Neuronal System—BRAF—skin cancer	6.79e-06	0.00279	CbGpPWpGaD
Nicotine—CHRNB2—SIDS Susceptibility Pathways—IL6—skin cancer	6.6e-06	0.00271	CbGpPWpGaD
Nicotine—CYP1A1—Arachidonic acid metabolism—PTGS2—skin cancer	6.52e-06	0.00268	CbGpPWpGaD
Nicotine—CHRNA5—Neuronal System—HRAS—skin cancer	6.5e-06	0.00267	CbGpPWpGaD
Nicotine—CHRNA7—Neuronal System—BRAF—skin cancer	6.44e-06	0.00265	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—SLC12A2—skin cancer	6.44e-06	0.00264	CbGpPWpGaD
Nicotine—CHRNA6—Transmission across Chemical Synapses—HRAS—skin cancer	6.43e-06	0.00264	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—CDK4—skin cancer	6.36e-06	0.00261	CbGpPWpGaD
Nicotine—CHRNA2—Neuronal System—BRAF—skin cancer	6.06e-06	0.00249	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—SLC12A2—skin cancer	6e-06	0.00246	CbGpPWpGaD
Nicotine—MAOB—Metabolism—PLIN2—skin cancer	6e-06	0.00246	CbGpPWpGaD
Nicotine—CYP2C8—Arachidonic acid metabolism—PTGS2—skin cancer	5.98e-06	0.00246	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—ENO2—skin cancer	5.97e-06	0.00245	CbGpPWpGaD
Nicotine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	5.92e-06	0.00243	CbGpPWpGaD
Nicotine—CHRNB2—Circadian rythm related genes—TP53—skin cancer	5.89e-06	0.00242	CbGpPWpGaD
Nicotine—CHRNB2—Transmission across Chemical Synapses—HRAS—skin cancer	5.66e-06	0.00232	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—BRAF—skin cancer	5.63e-06	0.00231	CbGpPWpGaD
Nicotine—CHAT—Neuronal System—HRAS—skin cancer	5.52e-06	0.00227	CbGpPWpGaD
Nicotine—CHAT—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.49e-06	0.00225	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—skin cancer	5.43e-06	0.00223	CbGpPWpGaD
Nicotine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	5.42e-06	0.00222	CbGpPWpGaD
Nicotine—CHRNB2—Circadian rythm related genes—IL6—skin cancer	5.39e-06	0.00221	CbGpPWpGaD
Nicotine—CYP2C19—Arachidonic acid metabolism—PTGS2—skin cancer	5.34e-06	0.00219	CbGpPWpGaD
Nicotine—CHRNA4—Neuronal System—BRAF—skin cancer	5.25e-06	0.00216	CbGpPWpGaD
Nicotine—CHRNB4—SIDS Susceptibility Pathways—IL6—skin cancer	5.2e-06	0.00214	CbGpPWpGaD
Nicotine—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	5.14e-06	0.00211	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PLIN2—skin cancer	5.07e-06	0.00208	CbGpPWpGaD
Nicotine—CHRNA6—Neuronal System—HRAS—skin cancer	4.92e-06	0.00202	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	4.89e-06	0.00201	CbGpPWpGaD
Nicotine—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	4.87e-06	0.002	CbGpPWpGaD
Nicotine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	4.83e-06	0.00199	CbGpPWpGaD
Nicotine—MAOB—Metabolism—CSPG4—skin cancer	4.83e-06	0.00198	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	4.67e-06	0.00192	CbGpPWpGaD
Nicotine—MAOA—Transmission across Chemical Synapses—BRAF—skin cancer	4.61e-06	0.00189	CbGpPWpGaD
Nicotine—CHRNA7—SIDS Susceptibility Pathways—IL6—skin cancer	4.51e-06	0.00185	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	4.48e-06	0.00184	CbGpPWpGaD
Nicotine—CHRNB4—Transmission across Chemical Synapses—HRAS—skin cancer	4.45e-06	0.00183	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	4.45e-06	0.00183	CbGpPWpGaD
Nicotine—CHRNB2—Neuronal System—HRAS—skin cancer	4.33e-06	0.00178	CbGpPWpGaD
Nicotine—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	4.19e-06	0.00172	CbGpPWpGaD
Nicotine—CYP1A2—Arachidonic acid metabolism—PTGS2—skin cancer	4.16e-06	0.00171	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—CSPG4—skin cancer	4.09e-06	0.00168	CbGpPWpGaD
Nicotine—CHAT—Metabolism—ERCC2—skin cancer	4.08e-06	0.00167	CbGpPWpGaD
Nicotine—CHRNA3—Transmission across Chemical Synapses—HRAS—skin cancer	4.07e-06	0.00167	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	4e-06	0.00164	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	3.97e-06	0.00163	CbGpPWpGaD
Nicotine—SLC22A2—Transmission across Chemical Synapses—BRAF—skin cancer	3.9e-06	0.0016	CbGpPWpGaD
Nicotine—CHRNA7—Transmission across Chemical Synapses—HRAS—skin cancer	3.87e-06	0.00159	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PLIN2—skin cancer	3.76e-06	0.00154	CbGpPWpGaD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—IL6—skin cancer	3.68e-06	0.00151	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PLIN2—skin cancer	3.67e-06	0.00151	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.65e-06	0.0015	CbGpPWpGaD
Nicotine—CHRNA2—Transmission across Chemical Synapses—HRAS—skin cancer	3.63e-06	0.00149	CbGpPWpGaD
Nicotine—SLC22A1—Transmission across Chemical Synapses—BRAF—skin cancer	3.63e-06	0.00149	CbGpPWpGaD
Nicotine—MAOA—Neuronal System—BRAF—skin cancer	3.53e-06	0.00145	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—ERCC2—skin cancer	3.47e-06	0.00142	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	3.46e-06	0.00142	CbGpPWpGaD
Nicotine—CHRNB4—Neuronal System—HRAS—skin cancer	3.41e-06	0.0014	CbGpPWpGaD
Nicotine—MAOB—Metabolism—ENO2—skin cancer	3.29e-06	0.00135	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PLIN2—skin cancer	3.18e-06	0.00131	CbGpPWpGaD
Nicotine—CHRNA4—Transmission across Chemical Synapses—HRAS—skin cancer	3.15e-06	0.00129	CbGpPWpGaD
Nicotine—CHRNA3—Neuronal System—HRAS—skin cancer	3.12e-06	0.00128	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.12e-06	0.00128	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—KRAS—skin cancer	3.04e-06	0.00125	CbGpPWpGaD
Nicotine—MAOA—Metabolism—CSPG4—skin cancer	3.03e-06	0.00125	CbGpPWpGaD
Nicotine—SLC22A2—Neuronal System—BRAF—skin cancer	2.98e-06	0.00123	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	2.98e-06	0.00122	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PLIN2—skin cancer	2.97e-06	0.00122	CbGpPWpGaD
Nicotine—CHRNA7—Neuronal System—HRAS—skin cancer	2.96e-06	0.00122	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—CSPG4—skin cancer	2.96e-06	0.00121	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PLIN2—skin cancer	2.92e-06	0.0012	CbGpPWpGaD
Nicotine—CHRNA2—Neuronal System—HRAS—skin cancer	2.78e-06	0.00114	CbGpPWpGaD
Nicotine—SLC22A1—Neuronal System—BRAF—skin cancer	2.78e-06	0.00114	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—ENO2—skin cancer	2.78e-06	0.00114	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—TP53—skin cancer	2.7e-06	0.00111	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—CSPG4—skin cancer	2.56e-06	0.00105	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	2.53e-06	0.00104	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—IL6—skin cancer	2.47e-06	0.00102	CbGpPWpGaD
Nicotine—CHAT—Metabolism—PTGS2—skin cancer	2.44e-06	0.001	CbGpPWpGaD
Nicotine—CHRNA4—Neuronal System—HRAS—skin cancer	2.41e-06	0.000991	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CSPG4—skin cancer	2.39e-06	0.000981	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PLIN2—skin cancer	2.36e-06	0.000968	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CSPG4—skin cancer	2.35e-06	0.000967	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PLIN2—skin cancer	2.31e-06	0.000948	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PLIN2—skin cancer	2.18e-06	0.000894	CbGpPWpGaD
Nicotine—MAOA—Transmission across Chemical Synapses—HRAS—skin cancer	2.12e-06	0.00087	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—PTGS2—skin cancer	2.08e-06	0.000853	CbGpPWpGaD
Nicotine—MAOA—Metabolism—ENO2—skin cancer	2.06e-06	0.000846	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—ENO2—skin cancer	2.01e-06	0.000826	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PLIN2—skin cancer	2e-06	0.000819	CbGpPWpGaD
Nicotine—MAOB—Metabolism—ERCC2—skin cancer	1.91e-06	0.000783	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CSPG4—skin cancer	1.9e-06	0.00078	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CSPG4—skin cancer	1.86e-06	0.000764	CbGpPWpGaD
Nicotine—SLC22A2—Transmission across Chemical Synapses—HRAS—skin cancer	1.79e-06	0.000735	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PLIN2—skin cancer	1.78e-06	0.000731	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CSPG4—skin cancer	1.75e-06	0.00072	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—ENO2—skin cancer	1.74e-06	0.000716	CbGpPWpGaD
Nicotine—SLC22A1—Transmission across Chemical Synapses—HRAS—skin cancer	1.67e-06	0.000685	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PLIN2—skin cancer	1.64e-06	0.000673	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—ENO2—skin cancer	1.62e-06	0.000667	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PLIN2—skin cancer	1.62e-06	0.000667	CbGpPWpGaD
Nicotine—MAOA—Neuronal System—HRAS—skin cancer	1.62e-06	0.000666	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—ERCC2—skin cancer	1.61e-06	0.000663	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CSPG4—skin cancer	1.61e-06	0.00066	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—ENO2—skin cancer	1.6e-06	0.000657	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.57e-06	0.000646	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CSPG4—skin cancer	1.44e-06	0.000589	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PLIN2—skin cancer	1.39e-06	0.00057	CbGpPWpGaD
Nicotine—SLC22A2—Neuronal System—HRAS—skin cancer	1.37e-06	0.000564	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CSPG4—skin cancer	1.32e-06	0.000542	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CSPG4—skin cancer	1.31e-06	0.000537	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—ENO2—skin cancer	1.29e-06	0.00053	CbGpPWpGaD
Nicotine—SLC22A1—Neuronal System—HRAS—skin cancer	1.28e-06	0.000525	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—ENO2—skin cancer	1.26e-06	0.000519	CbGpPWpGaD
Nicotine—MAOA—Metabolism—ERCC2—skin cancer	1.2e-06	0.000492	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—ENO2—skin cancer	1.19e-06	0.00049	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—ERCC2—skin cancer	1.17e-06	0.00048	CbGpPWpGaD
Nicotine—MAOB—Metabolism—PTGS2—skin cancer	1.14e-06	0.00047	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CSPG4—skin cancer	1.12e-06	0.000459	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—ENO2—skin cancer	1.09e-06	0.000449	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PLIN2—skin cancer	1.07e-06	0.00044	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—ERCC2—skin cancer	1.01e-06	0.000416	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ENO2—skin cancer	9.76e-07	0.000401	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PTGS2—skin cancer	9.68e-07	0.000397	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—ERCC2—skin cancer	9.44e-07	0.000388	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	9.32e-07	0.000383	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—ERCC2—skin cancer	9.3e-07	0.000382	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ENO2—skin cancer	8.97e-07	0.000368	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ENO2—skin cancer	8.9e-07	0.000365	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CSPG4—skin cancer	8.63e-07	0.000354	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	8.55e-07	0.000351	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	7.63e-07	0.000313	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ENO2—skin cancer	7.6e-07	0.000312	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—ERCC2—skin cancer	7.5e-07	0.000308	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—ERCC2—skin cancer	7.35e-07	0.000302	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PTGS2—skin cancer	7.18e-07	0.000295	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PTGS2—skin cancer	7e-07	0.000288	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.96e-07	0.000286	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—ERCC2—skin cancer	6.93e-07	0.000284	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—ERCC2—skin cancer	6.35e-07	0.000261	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PTGS2—skin cancer	6.07e-07	0.000249	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.95e-07	0.000244	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ENO2—skin cancer	5.87e-07	0.000241	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ERCC2—skin cancer	5.67e-07	0.000233	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PTGS2—skin cancer	5.66e-07	0.000232	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PTGS2—skin cancer	5.57e-07	0.000229	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ERCC2—skin cancer	5.21e-07	0.000214	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ERCC2—skin cancer	5.17e-07	0.000212	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PTGS2—skin cancer	4.5e-07	0.000185	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ERCC2—skin cancer	4.42e-07	0.000181	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PTGS2—skin cancer	4.4e-07	0.000181	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PTGS2—skin cancer	4.15e-07	0.000171	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PTGS2—skin cancer	3.81e-07	0.000156	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ERCC2—skin cancer	3.41e-07	0.00014	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PTGS2—skin cancer	3.4e-07	0.00014	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PTGS2—skin cancer	3.13e-07	0.000128	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PTGS2—skin cancer	3.1e-07	0.000127	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PTGS2—skin cancer	2.65e-07	0.000109	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PTGS2—skin cancer	2.04e-07	8.39e-05	CbGpPWpGaD
